{"id":"W4402356242","doi":"10.1097/coc.0000000000001143","title":"Efficacy and Safety of Abemaciclib in Combination With Endocrine Therapy for HR+/HER2− Advanced or Metastatic Breast Cancer","year":2024,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fulvestrant; Internal medicine; Oncology; Hazard ratio; Metastatic breast cancer; Breast cancer; Adverse effect; Combination therapy; Cancer; Confidence interval; Tamoxifen","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005778381,0.0008079789,0.006002585,0.002126377,0.0002606592,0.001583243,0.0007675044,0.0011013,0.002478777],"category_scores_gemma":[0.009854014,0.0004429273,0.008167489,0.001786796,0.0005363822,0.00102868,0.0005258411,0.001078586,0.0002032277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00109506,"about_ca_system_score_gemma":0.001543534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001234447,"about_ca_topic_score_gemma":0.003156614,"domain_scores_codex":[0.9961333,0.002017743,0.0009346357,0.0003075055,0.0005140877,0.00009267748],"domain_scores_gemma":[0.99497,0.002905063,0.001575195,0.0001078776,0.0003370244,0.0001049349],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.05365105,0.0005978835,0.004078035,0.5401716,0.1634044,0.0002512038,0.0001649402,0.001272227,0.003329237,0.0004623931,0.00208966,0.2305274],"study_design_scores_gemma":[0.04434612,0.03041669,0.03171509,0.1221708,0.7367808,0.001616549,0.0003531296,0.001640758,0.004615623,0.001444652,0.0246995,0.0002002905],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02279548,0.9749045,0.0002375507,0.0002542946,0.0001300842,0.000301839,0.0002698562,0.00001550105,0.001090981],"genre_scores_gemma":[0.429509,0.5650302,0.001927904,0.001340599,0.0004735534,0.000561468,0.000543395,0.00001738326,0.0005966697],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006002585,"threshold_uncertainty_score":0.03055942,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1099644072603908,"score_gpt":0.5343017928638563,"score_spread":0.4243373856034655,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}